Ultra-high Density SNParray in Neuroblastoma Molecular Diagnostics

Ultra-high Density SNParray in Neuroblastoma Molecular Diagnostics

Neuroblastoma serves as a paradigm for applying tumor genomic data for determining patient prognosis and thus for treatment allocation. MYCN status, i.e. amplified vs. non-amplified, was one of the very first biomarkers in oncology to discriminate aggressive from less aggressive or even favorable cl...

Full description

Bibliographic Details
Main Authors: Inge M. Ambros, Clemens eBrunner, Reza eAbbasi, Christian eFrech, Peter F. Ambros
Format: Article
Language:English
Published: Frontiers Media S.A. 2014-08-01
Series:Frontiers in Oncology
Subjects:
Neuroblastoma
Amplification
genetic risk factors
Genomic
chromothripsis
precision medicine
Online Access:http://journal.frontiersin.org/Journal/10.3389/fonc.2014.00202/full

Internet

http://journal.frontiersin.org/Journal/10.3389/fonc.2014.00202/full

Similar Items